Authors
Latest:
Bringing biologics to eye healthOphthalmologists, optometrists gain nonpharmacological treatment options for some of the eye’s most complex issues, providing better outcomes.
Latest:
Throwing everything away ... except the patient and the surgeonSingle-use cataract surgery comes with several safety and quality attributes.
Latest:
AI-related innovations for laser cataract technology mark a milestone in history of deviceThe integration of artificial intelligence in laser cataract technology is shifting the paradigm for the future of cataract surgery and is driving increased precision and improved outcomes for patients.
Latest:
Early outer retinal findings on en face and cross-sectional OCTRhegmatogenous retinal detachment studied.
Latest:
Innovation and the clinician-scientistA discussion with Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD.
Latest:
Novel approaches to treating severe ocular surface and corneal damageSevere ocular surface and corneal damage an unseen public health burden.
Latest:
Taking care of your patients’ eyes in a digital worldIt is important for patients to understand what digital eye strain is and its causes.
Latest:
ARVO 2025: Barsha Lal, PhD, presents an atropine study that addresses families' accomodative concernsA one-drop, low dose atropine study assesses accommodative amplitude and dynamics, with clinically applicable findings.
Latest:
Artificial DMEK could help tackle endothelial donor tissue shortageNew acrylic implant provides option for patients with endothelial dysfunction.
Latest:
BLOG: The PTVT Trial and Clinical ApplicationsJoseph F. Panarelli MD, Steven J. Gedde, MD, and Vikram Paranjpe MD, MPH discuss the Primary Tube Versus Trabeculectomy (PTVT) study.
Latest:
The search for an antifibrotic drug for use with pediatric glaucoma devicesInflammation and scarring are the primary obstacles with pirfenidone.
Latest:
Rethinking dry eye disease with acute steroid treatmentAccording to Lisa Nijm, MD, JD, patients can benefit from short-term, on-label treatment with a novel loteprednol formulation
Latest:
NeuroOp Guru: Neuro-Ophthalmology interprofessional eConsultsAndrew Lee, MD, Andrew Carey, MD, and Elizabeth Fortin, MD, sit down on this episode of the NeuroOp Guru to discuss neuro-ophthalmology, interprofessional eConsults, and whether they provide timely and valuable guidance
Latest:
Pediatric ocular surface reconstruction: Managing lesion excision challengesThis population requires careful attention from diagnosis through the entire postoperative process.
Latest:
Beyond mentoring: The power of sponsorship and advocacy in ophthalmologyTo create lasting change, ophthalmology must embrace the impact of sponsorship and advocacy—empowering the next generation of leaders with not just knowledge, but the opportunities to excel.
Latest:
Increasing your practice’s reach, relevance, and revenue with clinical trialsWorking as an investigator can prove to be a positive experience for physicians
Latest:
Q&A: The ELEVATUM Study with J. Fernando ArevaloThe ELEVATUM study explored faricimab's effectiveness in treating diabetic macular edema among underrepresented minorities, showcasing significant visual acuity improvements.
Latest:
Treating traumatic brain injury neuro-optometricallyPhysicians note the impact of prism lenses can be life-changing for patients.
Latest:
Ravi Patel, MD, shares ASCRS 2025 insights on enVista ASPIRE IOL user experienceDiscover how real-world evidence shapes cataract surgery practices, highlighting user satisfaction with enhanced monofocal IOLs at the 2025 ASCRS Annual Meeting.
Latest:
A Case of Neovascular AMD With Recurrent Subretinal FluidA retina specialist analyzes a case of neovascular age-related macular degeneration characterized by recurring subretinal fluid.
Latest:
Unmet Needs and the Future of Wet AMD CareExpert panelists provide an overview of current unmet needs in wet AMD care and discuss the potential for improving clinical outcomes and treatment burden.
Latest:
Tackling negotiations for contractsOn the 'Negotiations' episode of RWO: The Podcast, Dr. Lisa Nijm joins Drs. Nicole Bajic and Grayson Armstrong to discuss personal experiences with contract negotiation.
Latest:
Tear film imager may shift paradigm in the treatment of dry eye diseaseTFI employs spectral interference technology to image and map the corneal surface.
Latest:
Bridging disciplines and elevating care: A Q&A with John Gelles, OD, and Steven Greenstein, MDIn this Q&A, John D. Gelles, OD, and Steven Greenstein, MD, chat about what inspired them to launch the symposium, what makes this year’s agenda especially exciting, and why the future of refractive care depends on stronger collaboration between ODs and MDs.
Latest:
ASCRS 2025: Pinpointing your "why" and brushing up on clinical skills are vital to humanitarian ophthalmologyShehzad Batliwala, DO, known to his patients as Dr. Shehz, appeared on the ASCRS Foundation Symposium, where he discussed performing refractive surgery in low-resource, high-risk areas.
Latest:
Envision Summit 2025: Beyond the status quo in gene therapyAt the Envision Summit 2025 in San Juan, Puerto Rico, Mike Farkas, MD, discussed gene therapy research for retinal degenerations that sidetracks the current "status quo" therapies of AAV-based replacement and CRISPR-Cas9 genome editing.
Latest:
ARVO 2025: Retina extracellular vesicles in diabetic retinopathyAt ARVO 2025, in Salt Lake City, Utah, Emma Lessieur-Contreras, MD, PhD, talked about her poster on retina extracellular vesicles, and the role that they play on diabetic retinopathy.
Latest:
Q&A: Malvina Eydelman, MD, on leading CCOI and catalyzing global ophthalmic innovationShifting from a regulatory role to driving innovation directly, Eydelman discusses how the Collaborative Community on Ophthalmic Innovation is reshaping the field, streamlining outdated processes, and advancing patient-centered solutions worldwide.
